abstract |
The invention relates to a nucleotide analog, a method for obtaining a nucleotide analog, the use of a nucleotide analog, an antiviral pro-nucleotide and a pharmaceutical composition. More specifically, the invention relates to a new group of nucleotide derivatives and their use in the partial or complete inhibition of human immunodeficiency virus (HIV) multiplication. |